Pneumococcal vaccine for risk groups 2024 (2025, 2026 and 2027)

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) requested tenders for Pneumococcal Vaccines for risk groups belonging to the National Vaccination Programme in Finland.

The purpose of STM and the Customer was to procure Pneumococcal Vaccines for risk groups required for the National Vaccination Programme in Finland. The tendered vaccine must be suitable for patients 74-year-old and under according to vaccine's Summary of Product Characteristics (SPC). Target group for risk group vaccinations is patients under 75-year-old with severe chronic disease (for example kidney disease or severe lung disease). Finnish Institute for Health and Welfare reserves the right to change and update the definition of risk groups when needed. More information about National Vaccination Programme and vaccinations can be found on the website of the Finnish Institute for Health and Welfare: https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/pneumokokkirokotteet The Customer will implement the procurement on behalf of STM.

Tenderers may ask clarification questions using the Supplier Portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered. All times given in the Call for tender refer to local time in Finland.

Price is not the only award criterion and all criteria are stated only in the procurement documents. Reference price takes into account the differences in the impact of the vaccine both to the disease burden and to the health care costs. This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the Hilma.